VERU Similar Chart Price Prediction
The price of VERU is predicted to go up 21.87%, based on the high correlation periods with CLEU. The similarity of these two price pattern on the periods is 98.32%.
VERU
CLEU
Up: 21.87%Similarity: 98.32%
VERU Revenue Forecast
VERU EPS Forecast
VERU Analyst's Forecast
Leland Gershell
Oppenheimer
Buy
2024-11-05
Price Target
$5
Upside
+572.68%
Oppenheimer notes that Veru presented a meta-analysis of results from four prior placebo-controlled Phase 2 and 3 clinical studies of enobosarm at the ObesityWeek meeting. The firm, which remains positive on the opportunity for enobosarm to pair with GLP-1-based therapy to yield higher-quality and more weight loss, would be buyers ahead of January's top line readout from the Phase 2b QUALITY trial, says the analyst, who keeps an Outperform rating and $5 price target on Veru shares.
